The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GENE Detailed Price Forecast - CNN Money||View GENE Detailed Summary - Google Finance|
|View GENE Detailed Summary - Yahoo! Finance||View GENE Stock Research & Analysis - Zacks.com|
|View GENE Trends & Analysis - Trade-Ideas||View GENE Major Holders - Barrons|
|View GENE Call Transcripts - NASDAQ||View GENE Breaking News & Analysis - Seeking Alpha|
|View GENE Annual Report - CompanySpotlight.com||View GENE OTC Short Report - OTCShortReport.com|
|View GENE Fundamentals - TradeKing||View GENE SEC Filings - Bar Chart|
|View Historical Prices for GENE - The WSJ||View Performance/Total Return for GENE - Morningstar|
|View the Analyst Estimates for GENE - MarketWatch||View the Earnings History for GENE - CNBC|
|View the GENE Earnings - StockMarketWatch||View GENE Buy or Sell Recommendations - MacroAxis|
|View the GENE Bullish Patterns - American Bulls||View GENE Short Pain Metrics - ShortPainBot.com|
|View GENE Stock Mentions - StockTwits||View GENE Stock Mentions - PennyStockTweets|
|View GENE Stock Mentions - Twitter||View GENE Investment Forum News - Investor Hub|
|View GENE Stock Mentions - Yahoo! Message Board||View GENE Stock Mentions - Seeking Alpha|
|View Insider Transactions for GENE - SECform4.com||View Insider Transactions for GENE - Insider Cow|
|View GENE Major Holdings Summary - CNBC||View Insider Disclosure for GENE - OTC Markets|
|View Insider Transactions for GENE - Yahoo! Finance||View Institutional Holdings for GENE - NASDAQ|
|View GENE Stock Insight & Charts - FinViz.com||View GENE Investment Charts - StockCharts.com|
|View GENE Stock Overview & Charts - BarChart||View GENE User Generated Charts - Trading View|
Genetic Technologies Stock Up on Genetic Test Update
Posted on Monday July 16, 2018
Today, Genetic Technologies (GENE) was trading over 70% higher than yesterday’s closing price of $1.09. The stock jumped ~72.5% in premarket trading. The stock price and volumes rose on the news of the company’s on-track breast cancer and colorectal cancer risk assessment tests, slated for release in October.
Benzinga Pro's 5 Stocks To Watch Today
Posted on Monday July 16, 2018
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Coda Octopus Group, Inc. (NASDAQ: CODA ) stock soared ...
MELBOURNE, Australia, July 16, 2018-- Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, announced today that ...
Genetic Technologies Announces Heads of Agreement with Swisstec
Posted on Tuesday June 19, 2018
Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”, “GTG”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, is pleased to announce that it has entered into a Heads of Agreement with Swisstec Health Analytics Ltd. (“Swisstec”) to work together over the next 30 days to finalise a Proposed Joint Venture (PJV) to establish a new Company, (“JV Company”). The JV Company will enable both companies to collaborate to develop a service platform using blockchain technology that will provide a marketplace for medical services and personalised health management, and will also facilitate data management and AI-based services to promote better patient outcomes.